Skin News and Research

RSS

Four clinical centers to provide NovoTTF device treatment for recurrent GBM

Novocure, a commercial stage private oncology company, has announced that prominent neuro-oncologists at four clinical centers in the U.S. will be the first to provide access to its Tumor Treating Fields (TTFields) device, NovoTTF-100A System, for the treatment of recurrent glioblastoma multiforme. GBM is a deadly brain tumor affecting approximately 10,000 Americans each year.

3 Dec 2011

World Cell Race pulls 70 entries for title of world's fastest cell

A "team" of fast-moving, bone marrow stem cells from a research laboratory in Singapore has run away with the first World Cell Race, finishing first with a cellular speed record of 5.2 microns per minute (or 0.000204 inches per minute) in results announced today at the 51st Annual Meeting of the American Society for Cell Biology (ASCB).

3 Dec 2011

University of Illinois Hospital prescribes Tumor Treating Fields therapy for recurrent GBM

The University of Illinois Hospital is the first center in North America to prescribe a new FDA-approved treatment for patients with the most common and aggressive type of brain tumor, glioblastoma multiforme, or GBM.

3 Dec 2011

Pfizer acquires Excaliard

Pfizer Inc. announced today that it has completed its acquisition of Excaliard Pharmaceuticals, Inc., a privately owned biopharmaceutical company focused on developing novel drugs for the treatment of skin fibrosis, more commonly referred to as skin scarring.

3 Dec 2011

UA researchers receive NSF grant to develop terahertz spectral imager

Researchers at the University of Arizona College of Engineering have been awarded $530,000 to develop a unique piece of scientific equipment that will further spectral imaging research.

2 Dec 2011

White tea, witch hazel and rose have potential health and beauty properties

Age-old remedies could hold the key to treating a wide range of serious medical problems, as well as keeping skin firmer and less wrinkled, according to scientists from London's Kingston University.

2 Dec 2011

Researchers discover why men more likely than women to develop squamous cell skin cancer

Men are three times more likely than women to develop a common form of skin cancer but medical science doesn't know why. A new study may provide part of the answer.

2 Dec 2011

Northwestern researchers receive NIAMSD grant to study scleroderma

Northwestern Medicine researchers have received two five-year grants totaling $953,000 from the National Institutes of Health's (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to study scleroderma, an autoimmune disease for which there currently is no cure.

2 Dec 2011

NYU Langone establishes new LVAD Program for patients with advanced heart failure

The Cardiac & Vascular Institute at NYU Langone Medical Center has established its new LVAD Program. This surgical intervention program offers eligible, advanced heart failure patients implantation of the latest, lifesaving tool - a left ventricular assist device.

2 Dec 2011

FDA issues draft guidance on artificial pancreas system

The U.S. Food and Drug Administration today issued draft guidance designed to help investigators and manufacturers as they develop and seek approval for artificial pancreas device systems to treat type 1 diabetes.

2 Dec 2011

Body's surveillance for cancer causing damage and response to allergies share common pathway

CANCER RESEARCH UK scientists have found that the body's surveillance for cancer causing damage and its response to allergies share a common pathway, according to research published in Science on Thursday.

1 Dec 2011

Immune system stimulant used as suppressor to treat chronic graft-versus-host disease

In a study that seems to pivot on a paradox, scientists at Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell transplantation in cancer patients. The effect, in some cases, was profound.

1 Dec 2011

Scientists identify 700 anti-bacterial substances from nine species of odorous frogs

Some of the nastiest smelling creatures on Earth have skin that produces the greatest known variety of anti-bacterial substances that hold promise for becoming new weapons in the battle against antibiotic-resistant infections, scientists are reporting.

1 Dec 2011

Loyola to study vitamin D deficiency in people of African descent

Loyola University Chicago Stritch School of Medicine researchers have received a five-year, $2.8 million grant from the National Institutes of Health to study vitamin D deficiency in people of African descent.

1 Dec 2011

Nanoparticles do not penetrate beneath outermost layer of cells when applied to the skin

Ultra-tiny zinc oxide (ZnO) particles with dimensions less than one-ten-millionth of a meter are among the ingredients list of some commercially available sunscreen products, raising concerns about whether the particles may be absorbed beneath the outer layer of skin.

1 Dec 2011

Home visits, mobile clinics do not improve asthma outcomes in children

A new Johns Hopkins Children's Center study of Baltimore City children with asthma shows that two programs designed to improve disease outcomes among those who may be affected the worst fall short of expectations.

30 Nov 2011

Polarized filter may improve ability to detect precancerous changes, reduce unnecessary biopsies

The same filtered light that enables sunglasses to reduce glare may improve a physician's ability to detect early signs of cervical cancer, reducing unnecessary biopsies and surgery.

30 Nov 2011

Scientists regenerate functional muscle tissue in mice

A team of scientists from Worcester Polytechnic Institute (WPI) and CellThera, a private company located in WPI's Life Sciences and Bioengineering Center, have regenerated functional muscle tissue in mice, opening the door for a new clinical therapy to treat people who suffer major muscle trauma.

30 Nov 2011

Exposure to TCE, PERC and CCI4 may increase risk of Parkinson's

A University of Kentucky faculty member is a contributing author on a new study demonstrating a connection between a common solvent chemical and Parkinson's disease. Dr. Franca Cambi of the UK Kentucky Neuroscience Institute collaborated with researchers from across the U.S. on a paper recently published in the Annals of Neurology.

29 Nov 2011

Nanomedicine breakthrough by IBN and IBM named a ‘world changer’

A nanoparticle that can destroy drug-resistant bacteria developed by the Institute of Bioengineering and Nanotechnology (IBN), and the IBM Almaden Research Center, has recently been named one of 10 world changing ideas by Scientific American in its Technology Special Report ('World Changing Ideas – 10 New Technologies That Will Make a Difference', December 2011).

29 Nov 2011

Skin News and Research

Four clinical centers to provide NovoTTF device treatment for recurrent GBM

World Cell Race pulls 70 entries for title of world's fastest cell

University of Illinois Hospital prescribes Tumor Treating Fields therapy for recurrent GBM

Pfizer acquires Excaliard

UA researchers receive NSF grant to develop terahertz spectral imager

White tea, witch hazel and rose have potential health and beauty properties

Researchers discover why men more likely than women to develop squamous cell skin cancer

Northwestern researchers receive NIAMSD grant to study scleroderma

NYU Langone establishes new LVAD Program for patients with advanced heart failure

FDA issues draft guidance on artificial pancreas system

Body's surveillance for cancer causing damage and response to allergies share common pathway

Immune system stimulant used as suppressor to treat chronic graft-versus-host disease

Scientists identify 700 anti-bacterial substances from nine species of odorous frogs

Loyola to study vitamin D deficiency in people of African descent

Nanoparticles do not penetrate beneath outermost layer of cells when applied to the skin

Home visits, mobile clinics do not improve asthma outcomes in children

Polarized filter may improve ability to detect precancerous changes, reduce unnecessary biopsies

Scientists regenerate functional muscle tissue in mice

Exposure to TCE, PERC and CCI4 may increase risk of Parkinson's

Nanomedicine breakthrough by IBN and IBM named a ‘world changer’

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News